Back
Immunome, Inc. 10K Form
Sell
43
IMNM
Immunome, Inc.
Last Price:
$20.09
Seasonality Move:
57.07%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-03-25 | 10K | IMNM/Immunome, Inc. Annual |
| 2020-11-16 | 10Q | IMNM/Immunome, Inc. Quarterly |
Receive IMNM News And Ratings
See the #1 stock for the next 7 days that we like better than IMNM
IMNM Financial Statistics
Sales & Book Value
| Annual Sales: | $9M |
|---|---|
| Cash Flow: | $-41.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.88 |
| Price / Book: | 6.73 |
Profitability
| EPS (TTM): | -2.95620 |
|---|---|
| Net Income (TTM): | $-222.7M |
| Gross Margin: | $6.9M |
| Return on Equity: | -90.08% |
| Return on Assets: | -77.58% |
Immunome, Inc. Earnings Forecast
Key Immunome, Inc. Financial Ratios
-
The Gross Profit Margin over the past 7 years for IMNM is 76.75%.
-
The Selling, General & Administrative Expenses for IMNM have been equal to 364.51% of Gross Profit Margin.
-
The Research & Development expenses have been 1,409.58% of Revenue.
-
The Net Earning history of IMNM is -3,240.38% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 1 years.
Immunome, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | IMNM |
| Website: | immunome.com |
Debt
| Debt-to-Equity Ratio: | 0.02 |
|---|---|
| Current Ratio: | 8.9 |
| Quick Ratio: | 8.67 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
IMNM Technical Analysis vs Fundamental Analysis
Sell
43
Immunome, Inc. (IMNM)
is a Sell
Is Immunome, Inc. a Buy or a Sell?
-
Immunome, Inc. stock is rated a SellThe current Immunome, Inc. [IMNM] share price is $19.37. The Score for IMNM is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.